Bulletin · The UK skin assessment pathway · Q4 2026
A summary of our white paper on demand, capacity and the route to clinical decisions in UK skin care. Published by RADAR Skin Health.
The medical skin pathway has reached a point where increasing appointment capacity alone will not resolve the pressure. The evidence assembled for this Q4 2026 bulletin shows demand accelerating while specialist supply remains structurally constrained. [3, 6, 11] This makes it a critical time to redesign how skin presentations are assessed, prioritised and routed, so that patients reach the right clinical decision sooner and scarce specialist expertise is focused where it adds most value.
Skin disease is one of the largest and most varied areas of clinical demand in the UK. One in four people in England and Wales sees a GP about a skin condition each year. [1, 2] Most are managed in primary care, yet hospitals in England still recorded 4.25 million dermatology outpatient attendances in 2025–26, including 1.56 million first attendances in adult dermatology alone. [10] The challenge is moving a high volume of varied presentations from uncertainty to the right clinical decision, using scarce specialist time only where it adds value.
- First adult dermatology attendances
- 1.56m
- England, 2025–26 · Source 10
- Rise in urgent suspected skin cancer referrals in four years
- +57%
- October 2021 to October 2025 · Source 11
- Rise in urgent referrals for skin assessment in ten years
- +170%
- Source 4
- Dermatology treatment pathways waiting
- 423,217
- England, August 2026 · Source 3
- Within 18 weeks
- 69%
- Against a 92% standard · Source 3
- Of urgent skin cancer referrals confirmed as cancer
- 6%
- Source 4
Waiting-list statistics count pathways; outpatient figures count attendances. Neither is a count of unique patients.
1 · Demand is rising faster than specialist capacity
Melanoma has reached a record level, and urgent suspected skin cancer referrals in England rose by 57% in four years, from 44,149 a month in October 2021 to 69,452 in October 2025. The source projected that they would pass 800,000 in 2025–26, up from 715,803 in 2023–24. [6, 11] By January 2025 the dermatology waiting list stood 118% above its July 2020 level. [4]
The workforce cannot absorb that growth: the UK has 1,340 consultant dermatologists on the Specialist Register in the 2024 workforce evidence, BAD modelling puts the England shortfall at 89.5 whole-time-equivalent consultants, and around 27 WTE a year were expected to retire over the following five years. [5] NHS and private care draw on the same people: of 720 NHS consultants surveyed, 323 also work privately. [5]
57% growth in four years. Source: West Midlands Cancer Alliance, April 2026. [11]
2 · The pathway itself creates avoidable work
Each hand-off adds waiting and rework. Patients describe the same problem more than once, images are retaken, referrals are returned for missing information, and consultant time is spent reconstructing cases. The cost is felt most on the urgent pathway: only 6% of urgent suspected skin cancer referrals lead to a confirmed cancer diagnosis. At an illustrative 800,000 referrals a year, roughly 752,000 referrals would not result in confirmed cancer. Those patients may still need reassurance or other care. [4, 7, 11]
The bulletin places urgent referral activity alongside 1.56 million first adult dermatology attendances. These measures cover different activity and, in the full paper’s comparison, different years; they do not establish that urgent cancer referrals represent half of all new dermatology referrals. [10, 11]
3 · The output that matters is a decision, not an appointment
Most skin presentations need a safe decision about the right route. A structured history and clinically usable images make that decision possible early: a Royal Cornwall tele-triage pathway managed 49.8% of patients without a face-to-face assessment, with consultant review taking about 3 minutes instead of 20. [8] These are findings from one service, dependent on its case mix and imaging arrangements. Information quality is a capacity intervention.
4 · New models must not simply move the bottleneck
A remote front door only helps if it removes work rather than relocating it. If photos have to be retaken, specialists are asked to review cases with no time or funding set aside, or patients come back because their next step is unclear, the appointments saved simply reappear as work elsewhere. New models should therefore be judged across the whole episode: on safety, time to the right decision, total activity, patient experience and equity. [9]
What this means for private GPs and dermatologists
Four pressure points, their effect on the pathway, and where improvement lies.
| Pressure point | Effect | Improvement |
|---|---|---|
| 01 · Specialist capacity is finite and shared | Routine and lower-risk cases compete with complex and urgent patients for the same consultant time. | Focus specialist input on cases where it changes the decision, with advice and triage treated as planned, paid clinical work. |
| 02 · Information is inconsistent at referral | Histories are repeated, images retaken and referrals returned, creating delay and avoidable work. | Capture a structured history and clinically usable images once, then reuse them throughout the pathway. |
| 03 · An appointment is often the default | Patients wait for consultations when an earlier clinical decision might safely direct them elsewhere. | Introduce an earlier risk-based decision point, with clear routes into primary care, specialist advice, face-to-face review or urgent assessment. |
| 04 · Responsibility becomes fragmented | Patients experience unclear next steps, repeated contact and gaps in follow-up or safety-netting. | Define clinical ownership, inclusion criteria, response times, escalation rules and outcome tracking before introducing a new pathway. |
Clinician opinion
Next steps: read the evidence and see how your practice compares
This bulletin summarises a longer body of work. Go deeper into the analysis, see the approach tested in everyday general practice, and benchmark your own skin pathway.
Full white paper: the UK skin assessment pathway
The full analysis of demand, capacity and the route to clinical decisions in UK skin care, with 20 referenced sources.
Case study: 8 in 10 skin cases managed without a face-to-face GP appointment
Results from an eight-week tele-dermatology pilot in a UK GP practice: how structured remote triage was used to free clinical time and get patients answers faster. The study reports care decisions and workflow; it did not measure diagnostic accuracy or clinical resolution.
UK Skin Pathway Benchmark: take the 2-minute questionnaire
Tell us how your practice manages skin cases, and we will send you the findings report showing how your approach compares with other UK practices.
Get in touch or request a demo
See how RADAR Skin Health could work in your practice or clinic. We will walk you through the patient journey, the clinician review and how outcomes reach your records, and answer your questions on governance and integration.
Sources
- Getting It Right First Time. Dermatology: GIRFT Programme National Specialty Report. August 2021.
- NHS England. Referral optimisation for people with skin conditions. 27 September 2022.
- NHS Wait Helper. Dermatology waiting times, England: end of August 2026. Accessed 15 October 2026.
- British Association of Dermatologists. Dermatologists call for AI roadmap to help tackle UK’s most common cancer safely. Press release accompanying Integrating Innovation: Charting the course for AI in dermatology. 2 July 2025.
- British Association of Dermatologists. BAD Workforce Census Report 2023–24 and BAD Workforce Strategy. September 2024. Also see the Workforce Strategy.
- Cancer Research UK. Melanoma skin cancer cases hit a record high in the UK. 22 May 2026.
- UK Parliament. Written questions 113907 and 113908 on dermatology waiting lists and consultant vacancies, answered by Karin Smyth MP, Minister of State, Department of Health and Social Care. 2 March 2026.
- Royal Cornwall Hospitals NHS Trust. Award-winning tele-triage pathway helps to maintain first-class dermatology patient care. 7 February 2025.
- Getting It Right First Time. Dermatology: GIRFT Programme National Specialty Report. August 2021.
- NHS England. Hospital Outpatient Activity 2025–26: outpatient treatment specialty by attendance type (Dermatology, code 330; Paediatric Dermatology, code 257). 24 September 2026.
Full methodological context and references are given in The UK skin assessment pathway. This web edition retains the Q4 2026 source’s evidence dates and labels the 2025–26 annual urgent-referral figure as an estimate. Waiting-list and outpatient labels follow the source white paper’s methodology: pathways and attendances, not unique people. The source’s placeholder contact fields have been replaced with the website’s demonstration route.